Year-over-year earnings per share growth for the last twelve months: PDS Biotechnology (PDSB)
PDS Biotechnology management is effectively minimizing scientific risks by developing partnerships with industry behemoths. The quarterly EPS growth history on the general GURU.Markets platform chart confirms this trajectory, where the value of 14.60 reflects the metric's balance. Versamune technology enables the creation of universal tumor medications while optimizing costs, and the company's research capacities are fully prepared for the industrial scaling of these drugs.
Comprehensive metric breakdowns and analytics for PDS Biotechnology (PDSB)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt and liquidity details:
- earnings and market multiples details:
PDSB - Final Profit|Projected Future Earnings PDS Biotechnology|PDSB - Market Cap to Earnings|Future Price to Earnings pdsbiotech.com|PDSB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple PDS Biotechnology Corp|PDSB - Operating profit EBITDA|Earnings per share for the last twelve months PDS Biotechnology|PDSB - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months pdsbiotech.com|PDSB - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year PDS Biotechnology
Comprehensive company analysis:PDS Biotech, PDSB
PDS Biotechnology operates within an isolated product cycle where stable demand for biotechnology offsets macroeconomic risks. The earnings per share (EPS) dynamics quantify this resilience, measuring net income growth rates per quarter without time lags; analyzing the quarterly EPS growth trend allows investors to assess the fundamental viability of the business and promptly identify risks of the asset being overbought.
Competitors of PDS Biotechnology
IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Janux Pharma|Year-over-year net earnings per share growth for the last 12 months Arcus Corp (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc. (ZYME)|Year-over-year net earnings per share growth for the last 12 months tangotx.com TNGX|Iovance Biotherapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics NV IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (Compass Therapeutics Corp) - Year-over-year earnings per share growth for the last 12 months|Replimune Group, Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months lyell.com (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma, Inc.)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immix Biopharma, Inc.|ALX Oncology (ALXO) - Year-over-year earnings per share growth for the last twelve months|Cue Biopharma Inc. - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIABiotech.com|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Corp - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics Inc (LPTX) - Earnings per share growth in annualized terms for the last twelve months|INTS - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months SNSE|TOVX: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months GRTS|Year-over-year earnings per share growth for the last twelve months Kineta Bio|NexImmune Corporation (NEXI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months TSBX (Turnstone Biologics)|VCNX (vaccinex.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HARP (Harpoon Therapeutics, Inc.)
